ES2062450T3 - Sales metalicas bivalentes del acido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion. - Google Patents

Sales metalicas bivalentes del acido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion.

Info

Publication number
ES2062450T3
ES2062450T3 ES90402401T ES90402401T ES2062450T3 ES 2062450 T3 ES2062450 T3 ES 2062450T3 ES 90402401 T ES90402401 T ES 90402401T ES 90402401 T ES90402401 T ES 90402401T ES 2062450 T3 ES2062450 T3 ES 2062450T3
Authority
ES
Spain
Prior art keywords
carboximetil
amino
metal salts
acid
tiofeno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402401T
Other languages
English (en)
Other versions
ES2062450T4 (es
Inventor
Michel Wierzbicki
Jacqueline Bonnet
Martine Brisset
Yannis Tsouderos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2062450T3 publication Critical patent/ES2062450T3/es
Anticipated expiration legal-status Critical
Publication of ES2062450T4 publication Critical patent/ES2062450T4/es
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NUEVAS SALES DE METALES DIVALENTES DEL ACIDO N,N-DI(CARBOXIMETIL)AMINO-2 CIANO-3 CARBOXIMETIL-4 CARBOXI-5 TIOFENO, UTILIZABLES EN TERAPIA, ESPECIALMENTE EN EL TRATAMIENTO DE ENFERMEDADES OSEAS, ENVEJECIMIENTO CUTANEO Y VASCULARR, AFECCIONES HEPATICAS DENTALES.
ES90402401T 1989-09-01 1990-08-31 Sales metálicas bivalentes del ácido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion. Expired - Lifetime ES2062450T4 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911475A FR2651497B1 (fr) 1989-09-01 1989-09-01 Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR8911475 1989-09-01

Publications (2)

Publication Number Publication Date
ES2062450T3 true ES2062450T3 (es) 1994-12-16
ES2062450T4 ES2062450T4 (es) 2011-12-29

Family

ID=9385063

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402401T Expired - Lifetime ES2062450T4 (es) 1989-09-01 1990-08-31 Sales metálicas bivalentes del ácido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion.

Country Status (18)

Country Link
US (1) US5128367A (es)
EP (1) EP0415850B1 (es)
JP (1) JPH0692386B2 (es)
AT (1) ATE100093T1 (es)
AU (1) AU624022B2 (es)
CA (1) CA2024419C (es)
DE (2) DE122005000001I2 (es)
DK (1) DK0415850T3 (es)
ES (1) ES2062450T4 (es)
FR (1) FR2651497B1 (es)
HK (1) HK57097A (es)
IE (1) IE65157B1 (es)
LU (1) LU91125I2 (es)
NL (1) NL300168I2 (es)
NZ (1) NZ234770A (es)
OA (1) OA09463A (es)
PT (1) PT95184B (es)
ZA (1) ZA906716B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
JP5049589B2 (ja) * 2003-05-07 2012-10-17 オステオロジックス エイ／エス ストロンチウム塩含有の放出制御組成物
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
SI1622630T1 (sl) 2003-05-07 2012-12-31 Osteologix A/S Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti
US6905723B2 (en) * 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
KR101165614B1 (ko) 2004-02-26 2012-07-18 오스테올로지스 에이에스 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
EA011814B1 (ru) 2004-06-25 2009-06-30 Стронтин Апс Композиции, содержащие стронций и витамин d, и их применение
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
CA2619720A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
CN101229154B (zh) * 2007-01-26 2010-05-12 鲁南制药集团股份有限公司 治疗骨质疏松的药物组合物
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
CN102227419A (zh) 2008-09-29 2011-10-26 拉蒂奥法姆有限责任公司 无水和水合形式的雷奈酸锶
CN101747316B (zh) * 2008-12-12 2013-09-25 重庆医药工业研究院有限责任公司 高纯度的雷奈酸锶及其制备方法
EP2416756A2 (en) 2009-04-10 2012-02-15 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
CN101775002B (zh) * 2009-12-23 2015-07-15 浙江华海药业股份有限公司 一种制备雷尼酸锶的方法
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
IT1398542B1 (it) 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
CN102241663B (zh) * 2010-05-10 2013-02-13 山东方明药业集团股份有限公司 一种雷奈酸锶八水合物的制备方法
WO2012046251A2 (en) * 2010-10-08 2012-04-12 Glenmark Generics Limited Novel form of ranelic acid
CN102180864B (zh) * 2011-03-28 2012-12-12 中国药科大学 一种雷尼酸锶的制备方法
CZ2011320A3 (cs) 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102503931A (zh) * 2011-09-20 2012-06-20 浙江华海药业股份有限公司 一种雷尼酸锶晶形h的制备方法
WO2013113319A1 (en) 2012-01-31 2013-08-08 Pharmathen S.A. Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (en) 2012-03-23 2013-09-25 Urquima S.A. Solid forms of strontium ranelate and processes for their preparation
US8569514B1 (en) 2012-05-17 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of strontium ranelate
CN103804345B (zh) * 2013-09-06 2017-03-15 精华制药集团股份有限公司 一种用hplc法中控制备高纯度雷尼酸锶的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905577A1 (de) * 1989-02-23 1990-08-30 Basf Ag Diaminothiophene

Also Published As

Publication number Publication date
FR2651497B1 (fr) 1991-10-25
PT95184B (pt) 1997-06-30
US5128367A (en) 1992-07-07
NL300168I1 (nl) 2005-03-01
NL300168I2 (nl) 2005-03-01
ZA906716B (en) 1991-06-26
DE122005000001I1 (de) 2005-05-12
JPH03169876A (ja) 1991-07-23
EP0415850B1 (fr) 1994-01-12
OA09463A (fr) 1992-11-15
ES2062450T4 (es) 2011-12-29
NZ234770A (en) 1991-11-26
JPH0692386B2 (ja) 1994-11-16
DE69005950T2 (de) 1994-07-21
DE69005950D1 (de) 1994-02-24
DE122005000001I2 (de) 2006-02-09
CA2024419C (fr) 1999-07-20
PT95184A (pt) 1991-05-22
FR2651497A1 (fr) 1991-03-08
HK57097A (en) 1997-05-09
ATE100093T1 (de) 1994-01-15
LU91125I2 (fr) 2005-02-15
DK0415850T3 (da) 1994-03-21
IE65157B1 (en) 1995-10-04
AU624022B2 (en) 1992-05-28
AU6203390A (en) 1991-03-07
CA2024419A1 (fr) 1991-03-02
IE903162A1 (en) 1991-03-13
EP0415850A1 (fr) 1991-03-06

Similar Documents

Publication Publication Date Title
DK0415850T3 (da) Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ES509647A0 (es) Procedimiento para preparar una polilactida.
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60131569D1 (de) Genetisch veränderter herpes virus für die behandlung von herz- und gefässerkrankungen
ATE111735T1 (de) Verwendung des wirkstoffs azelastin und glycerinethern zur bekämpfung von psoriasis- erkrankungen.
NO893240L (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
IT8319306A0 (it) Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di malattie della pelle e delle unghie.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DK0549666T3 (da) Nye aminobenzosultamderivater og deres anvendelse som lipoxygenaseinhibitorer
FI911788A7 (fi) Difluoriglutamiinihapon konjugaatteja folaattien ja antifolaattien kanssa uudiskasvusairauksien hoitoa varten
NO921223D0 (no) Kombinasjonspreparat med antitrombotisk virkning
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
FI911778A7 (fi) Difluoriglutamiinihappo-konjugaatit folaattien ja antifolaattien kanssa neoplastisten sairauksien hoitoon
PT1228031E (pt) Derivados do acido 15-hidroxieicosatetraenoico modificados na cadeia omega e sua utilizacao no tratamento da secura ocular
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
IT8448370A0 (it) Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche
FI901607A7 (fi) Lääkeaine ja sen käyttö parasitoosin käsittelyyn
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
NO923078D0 (no) Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling
IT8720377A0 (it) Procedimento per la fabbricazione di fazzoletti igienici e fazzoletti del tipo usa e getta.
DE69201975D1 (de) Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 415850

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: PRODUCT NAME: RANELATO DE ESTRONCIO (PROTELOS), REGISTRY NO/DATE: EU/1/04/288/001-006 20040921, FIRST REGISTRY NO/DATE: UEEU/1/04/288/001-006 20040921

Spc suppl protection certif: C200500003

Filing date: 20050202

SPCG Supplementary protection certificate granted

Free format text: PRODUCT NAME: RANELATO DE ESTRONCIO (PROTELOS), REGISTRY NO/DATE: EU/1/04/288/001-006 20040921, FIRST REGISTRY NO/DATE: UEEU/1/04/288/001-0006 20040921

Spc suppl protection certif: C200500003

Filing date: 20050202